Pharma and Life Sciences Solutions
-
Learn MoreCredit Balances: The big benefits of a third-party approach
-
Learn MoreSuccessful COB Starts with Good Data
-
Learn MoreApplying targeted pharmacy audit solutions to help a nationwide health plan capture millions in recoveries.
-
Learn MoreApplying Predictive Analytics in Adherence Programs
It’s time for the pharmaceutical services industry to start widely applying predictive analytics — and introduce prescriptive analytics — to realize the significant benefits of improved adherence.
-
Learn MoreInnovations to Increase Healthcare Provider Access and Engagement
-
Learn MoreThe Role of Hubs in Patient Adherence
-
Learn MoreThe Evolution of Reimbursement and Access Services
-
Learn MoreToday's hub blueprint: Lock in on the journey
-
Learn MoreHybrid hubs and today's patient-centric push
-
Learn MoreThe Evolution of Pharma Sales: 4 Insights and Predictions
The pandemic permanently altered the pharmaceutical industry and required novel approaches to healthcare provider and patient engagement. Here are some ways that pharma sales will continue to evolve,
-
Learn MoreDrug Manufacturers Take A Fresh Look as PAPs Continue to Hold Spotlight
-
Learn Moree-Book: 3 Data-Driven Strategies to Build a Connected Healthcare Ecosystem
-
Learn MoreApplying Next Best Action Technology in Pharmaceutical Services
-
Learn MoreOvercoming Payer Barriers through the Three Pillars of Hub Onboarding: Rate, Time, Duration
Pharmaceutical manufacturers and payers are often at odds over pricing and barriers to new medication access. Payers will typically initiate a variety of cost containment initiatives,
-
Learn MoreeBook: Mission Critical - Staying resilient together in the face of uncertainty
-
Learn MoreTransforming Pharma Field Sales Requires Digitally Empowered Teams
Big data has the ability to transform pharma field sales — if pharma manufacturers can translate data into actionable insights and real-time outreach at the individual territory level.
-
Learn MorePatient-Focused Drug Development (PFDD) — the FDA Guidance that Changes How Life Sciences Works
The FDA is encouraging the industry to include patients in a meaningful way in drug development — from pre-IND through commercialization.
-
Loading More...
